메뉴 건너뛰기




Volumn 43, Issue 4, 2007, Pages 1476-1482

Isolation, structural elucidation and characterization of impurities in Cefdinir

Author keywords

Cefdinir; Characterization; Identification; Impurities; Preparative HPLC; Spectroscopy

Indexed keywords

7 [2 (2 AMINOTHIAZOL 4 YL) 2 HYDROXYIMINOACETAMIDO] 8 OXO 3 METHYL 5 THIA 1 AZABICYCLO[4.2.0]OCT 2 ENE CARBOXYLIC ACID; 7 [2 (2 AMINOTHIAZOL 4 YL) 2 HYDROXYIMINOACETAMIDO] 8 OXO 3 VINYL 5 THIA 1 AZABICYCLO[4.2.0]OCT 2 ENE CARBOXYLIC ACID; 7 [2 (2 AMINOTHIAZOL 4 YL) 2 HYDROXYIMINOACETAMIDO] 8 OXO 3 VINYL 5 THIA 1 AZABICYCLO[4.2.0]OCT 2 ENE CARBOXYLIC ACID 5 OXIDE; CEFDINIR; UNCLASSIFIED DRUG;

EID: 33847247263     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2006.10.031     Document Type: Article
Times cited : (18)

References (8)
  • 2
    • 33847329519 scopus 로고    scopus 로고
    • T. Takaya, T. Hisashi, US Patent No. 455,334, CA 101, 130505 h.
  • 8
    • 33847311165 scopus 로고    scopus 로고
    • ICH Guideline Q3A (R), Impurities in New Drug Substances, 7 February, 2002.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.